Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous ceftriaxone for acute spinal cord injury compared with methylprednisolone alone
IRCT2016102713947N5Phase 3Completed
- Sponsor
- Road Traffic Injury Prevention Research Center
- Start
- Dec 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of ceftriaxone and methylprednisolone in spinal cord injury (SCI) (2 arms), sponsored by Road Traffic Injury Prevention Research Center. Primary endpoint: Neurologic outcome. Started Dec 2016; status: completed.
02
Drugs
ceftriaxonemethylprednisolone
03
Conditions
spinal cord injury (SCI)
Beyond the preview
Go deeper on IRCT2016102713947N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016102713947N5.